FATE R&D Expense Growth
Fate Therapeutics Inc · R&D Expense Growth
FATE R&D Expense Growth
Latest reported-20.13%period ending
FATE FY R&D Growth (YoY) (0.00% → -20.13%)
Latest values, visible window
High-resolution chart · PNG
FATE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -20.1273% | |
| -21.7821% | |
| -46.1402% | |
| 48.6894% | |
| 71.5601% | |
| 43.1275% | |
| 56.665% | |
| 63.0595% | |
| 29.8881% | |
| 33.1856% | |
| 20.8458% | |
| 36.8785% | |
| 0.0667% | |
| 21.7184% | |
| 0% |